HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| 1 |
UnitedHealth
UNH
|
+$850M |
| 2 |
Visa
V
|
+$442M |
| 3 |
iShares TIPS Bond ETF
TIP
|
+$313M |
| 4 |
Avis
CAR
|
+$256M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.92B |
| 2 |
NVIDIA
NVDA
|
+$2.09B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.07B |
| 4 |
Meta Platforms (Facebook)
META
|
+$862M |
| 5 |
Galicia Financial Group
GGAL
|
+$602M |
Sector Composition
| 1 | Technology | 32.39% |
| 2 | Financials | 13.56% |
| 3 | Consumer Discretionary | 11.19% |
| 4 | Communication Services | 8.94% |
| 5 | Healthcare | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Cassava Sciences
SAVA
$101M
| $18.6K | ﹤0.01% |
10,105
-4,626
| -31% | -$8.51K |
|
2502
Sutro Biopharma
STRO
$76.8M
| $18.2K | ﹤0.01% |
24,739
-35,724
| -59% | -$26.2K |
|
2503
Fossil Group
FOSL
$166M
| $17.7K | ﹤0.01% |
11,844
| – | – |
|
2504
Getty Images
GETY
$801M
| $17.5K | ﹤0.01% |
10,642
-952
| -8% | -$1.56K |
|
2505
Hyliion Holdings
HYLN
$286M
| $17.4K | ﹤0.01% |
12,588
-7,521
| -37% | -$10.4K |
|
2506
LiveOne
LVO
$63.7M
| $16.5K | ﹤0.01% |
+21,962
| New | +$16.5K |
|
|
CLYM
2507
Climb Bio, Inc. Common Stock
CLYM
$152M
| $16.2K | ﹤0.01% |
13,296
-3,430
| -21% | -$4.18K |
|
|
TPIC
2508
DELISTED
TPI Composites
TPIC
| $16.2K | ﹤0.01% |
+18,178
| New | +$16.2K |
|
2509
Erasca
ERAS
$443M
| $14.3K | ﹤0.01% |
11,090
-17,484
| -61% | -$22.6K |
|
2510
Prelude Therapeutics
PRLD
$65.1M
| $13.9K | ﹤0.01% |
17,411
-3,219
| -16% | -$2.58K |
|
2511
BARK
BARK
$149M
| $13.9K | ﹤0.01% |
15,708
-4,635
| -23% | -$4.11K |
|
2512
Esperion Therapeutics
ESPR
$571M
| $13.8K | ﹤0.01% |
13,703
-8,132
| -37% | -$8.17K |
|
|
TE
2513
T1 Energy Inc.
TE
$287M
| $13.3K | ﹤0.01% |
10,802
-2,156
| -17% | -$2.66K |
|
2514
Shattuck Labs
STTK
$95.8M
| $12.9K | ﹤0.01% |
+16,122
| New | +$12.9K |
|
2515
Clear Channel Outdoor Holdings
CCO
$656M
| $12.1K | ﹤0.01% |
10,375
-40,563
| -80% | -$47.5K |
|
2516
Gores Guggenheim
PSNY
$1.98B
| $11.4K | ﹤0.01% |
+10,691
| New | +$11.4K |
|
2517
Mersana Therapeutics
MRSN
$36M
| $8.78K | ﹤0.01% |
1,220
+720
| +144% | +$5.18K |
|
2518
Ironwood Pharmaceuticals
IRWD
$210M
| $8.69K | ﹤0.01% |
12,351
-8,427
| -41% | -$5.93K |
|
2519
NextCure
NXTC
$14.5M
| $8.09K | ﹤0.01% |
1,438
| – | – |
|
2520
Ovid Therapeutics
OVID
$87.5M
| $6.01K | ﹤0.01% |
+19,220
| New | +$6.01K |
|
2521
ALX Oncology
ALXO
$58.9M
| $5.05K | ﹤0.01% |
12,306
-3,822
| -24% | -$1.57K |
|
2522
Rallybio
RLYB
$24.3M
| $3.5K | ﹤0.01% |
10,520
-1,534
| -13% | -$510 |
|
2523
MINISO
MNSO
$7.52B
| – | – |
-26,726
| Closed | -$501K |
|
|
MREO
2524
Mereo BioPharma
MREO
$294M
| – | – |
-13,577
| Closed | -$29.8K |
|
2525
Maravai LifeSciences
MRVI
$398M
| – | – |
-12,763
| Closed | -$29.2K |
|